000			01486 a2200397 4500
005			20250512102239.0
264		0	_c19720819
008			197208s 0 0 eng d
022			_a0002-9394
024	7		_a10.1016/0002-9394(72)91130-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aPavan-Langston, D
245	0	0	_aA double blind clinical study of adenine arabinoside therapy of viral keratoconjunctivitis. _h[electronic resource]
260			_bAmerican journal of ophthalmology _cJul 1972
300			_a81-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650	0	4	_aAdenine _xadverse effects
650	0	4	_aAdenoviridae Infections _xdrug therapy
650	0	4	_aAntiviral Agents
650	0	4	_aArabinose _xadverse effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aDrug Hypersensitivity
650	0	4	_aEvaluation Studies as Topic
650	0	4	_aHumans
650	0	4	_aIdoxuridine _xadverse effects
650	0	4	_aKeratitis, Dendritic _xdrug therapy
650	0	4	_aKeratoconjunctivitis _xdrug therapy
650	0	4	_aNucleosides _xadverse effects
650	0	4	_aTime Factors
650	0	4	_aUveitis _xdrug therapy
650	0	4	_aVaccinia _xdrug therapy
650	0	4	_aVirus Diseases _xdrug therapy
700	1		_aDohlman, C H
773	0		_tAmerican journal of ophthalmology _gvol. 74 _gno. 1 _gp. 81-8
856	4	0	_uhttps://doi.org/10.1016/0002-9394(72)91130-0 _zAvailable from publisher's website
999			_c4343472 _d4343472